{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:15:58Z","timestamp":1770815758027,"version":"3.50.1"},"reference-count":21,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tenofovir alafenamide (TAF) has been available in China for a short time, little is known about its safety and efficacy in patients with hepatitis B virus (HBV)\u2013related acute\u2010on\u2010chronic liver failure (HBV\u2010ACLF). We conducted this study to further verify the safety and efficacy of TAF in these patients. Eighty\u2010eight eligible subjects were included and divided into three groups: TAF group, TDF group and ETV group. Clinical and laboratory test results were collected and the survival status, virus suppression status and liver and renal function improvement were observed during follow\u2010up. No drug\u2010related adverse events were observed within a 48\u2010week observation period. At week 48, the survival rates of the three groups were 56.5%, 78.3% and 59.5% (<jats:italic>p<\/jats:italic>\u00a0=\u00a00.262). HBV DNA undetectable rates were similar (80.0% vs.75.0% vs.84.6%, respectively, <jats:italic>p\u00a0=\u00a0<\/jats:italic>0.863). Liver function improved in all the three groups over time. Compared with the other two groups, patients in the TAF group had a greater decrease in serum creatinine (CR) and an increase in estimated glomerular filtration rate (eGFR), especially at week 12. At week 48, the median changes of CR were \u22120.7 (IQR \u22123.0, 13.0) vs. 15.0 (IQR \u22123.0, 21.0) vs. 5.0 (IQR \u22129.0, 14.0), respectively (<jats:italic>p<\/jats:italic>\u202f=\u202f0.334), while the median changes of eGFR were \u22122.12 (IQR \u221213.87, 1.44) vs. \u221210.43 (IQR \u221220.21, 3.18) vs. \u22125.31 (IQR \u221214.72, 5.44) ml\/min\/1.73\u00a0m<jats:sup>2<\/jats:sup>, respectively (<jats:italic>p<\/jats:italic>\u202f=\u202f0.592). In this real\u2010world clinical study, TAF is as effective as TDF and ETV, and may be more beneficial in protecting renal function in the early stages of antiviral therapy.<\/jats:p>","DOI":"10.1111\/jvh.13468","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T03:24:35Z","timestamp":1610681075000},"page":"592-600","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The 48\u2010week safety and therapeutic effects of tenofovir alafenamide in hbv\u2010related acute\u2010on\u2010chronic liver failure: A prospective cohort study"],"prefix":"10.1111","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2324-8570","authenticated-orcid":false,"given":"Yeqiong","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases Third Affiliated Hospital of Sun Yat\u2010Sen University Guangzhou Guangdong China"},{"name":"Guangdong Key Laboratory of Liver Disease Research Third Affiliated Hospital of Sun Yat\u2010Sen University Guangzhou Guangdong China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxiong","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Third Affiliated Hospital of Sun Yat\u2010Sen University Guangzhou Guangdong China"},{"name":"Guangdong Key Laboratory of Liver Disease Research Third Affiliated Hospital of Sun Yat\u2010Sen University Guangzhou Guangdong China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Third Affiliated Hospital of Sun Yat\u2010Sen University Guangzhou Guangdong China"},{"name":"Guangdong Key Laboratory of Liver Disease Research Third Affiliated Hospital of Sun Yat\u2010Sen University Guangzhou Guangdong China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Third Affiliated Hospital of Sun Yat\u2010Sen University Guangzhou Guangdong China"},{"name":"Guangdong Key Laboratory of Liver Disease Research Third Affiliated Hospital of Sun Yat\u2010Sen University Guangzhou Guangdong China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianguo","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Third Affiliated Hospital of Sun Yat\u2010Sen University Guangzhou Guangdong China"},{"name":"Guangdong Key Laboratory of Liver Disease Research Third Affiliated Hospital of Sun Yat\u2010Sen University Guangzhou Guangdong China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Shu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Third Affiliated Hospital of Sun Yat\u2010Sen University Guangzhou Guangdong China"},{"name":"Guangdong Key Laboratory of Liver Disease Research Third Affiliated Hospital of Sun Yat\u2010Sen University Guangzhou Guangdong China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Third Affiliated Hospital of Sun Yat\u2010Sen University Guangzhou Guangdong China"},{"name":"Guangdong Key Laboratory of Liver Disease Research Third Affiliated Hospital of Sun Yat\u2010Sen University Guangzhou Guangdong China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junqiang","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Third Affiliated Hospital of Sun Yat\u2010Sen University Guangzhou Guangdong China"},{"name":"Guangdong Key Laboratory of Liver Disease Research Third Affiliated Hospital of Sun Yat\u2010Sen University Guangzhou Guangdong China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Third Affiliated Hospital of Sun Yat\u2010Sen University Guangzhou Guangdong China"},{"name":"Guangdong Key Laboratory of Liver Disease Research Third Affiliated Hospital of Sun Yat\u2010Sen University Guangzhou Guangdong China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Third Affiliated Hospital of Sun Yat\u2010Sen University Guangzhou Guangdong China"},{"name":"Guangdong Key Laboratory of Liver Disease Research Third Affiliated Hospital of Sun Yat\u2010Sen University Guangzhou Guangdong China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,1,19]]},"reference":[{"key":"e_1_2_11_2_1","volume-title":"Global Hepatitis Report, 2017","author":"World Health Organization","year":"2017"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29800"},{"issue":"11","key":"e_1_2_11_4_1","first-page":"401","article-title":"Guideline for diagnosis and treatment of liver failure (2018 Edition)","volume":"2018","author":"Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association","year":"2018","journal-title":"Chin J Clin Infect Dis"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314641"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2015.219"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2015.06.008"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-019-09946-3"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu471"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14497"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku502"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22841"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1053\/he.2000.5852"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.02.013"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(16)30107-8"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(16)30024-3"},{"issue":"18","key":"e_1_2_11_18_1","first-page":"30633","article-title":"Improved bone safety of tenofovir alafenamide compared to tenofovir disoproxil fumarate over 2 years in patients with chronic HBV infection","volume":"1542","author":"Seto WK","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.11.039"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41424-018-0007-6"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30246"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.2014.909724"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.13468","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jvh.13468","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.13468","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T22:14:57Z","timestamp":1693692897000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jvh.13468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,19]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1111\/jvh.13468"],"URL":"https:\/\/doi.org\/10.1111\/jvh.13468","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,19]]},"assertion":[{"value":"2020-11-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}